JP2003277288A5 - - Google Patents

Download PDF

Info

Publication number
JP2003277288A5
JP2003277288A5 JP2002376903A JP2002376903A JP2003277288A5 JP 2003277288 A5 JP2003277288 A5 JP 2003277288A5 JP 2002376903 A JP2002376903 A JP 2002376903A JP 2002376903 A JP2002376903 A JP 2002376903A JP 2003277288 A5 JP2003277288 A5 JP 2003277288A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
same
cancer
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002376903A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003277288A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2002376903A priority Critical patent/JP2003277288A/ja
Priority claimed from JP2002376903A external-priority patent/JP2003277288A/ja
Publication of JP2003277288A publication Critical patent/JP2003277288A/ja
Publication of JP2003277288A5 publication Critical patent/JP2003277288A5/ja
Pending legal-status Critical Current

Links

JP2002376903A 2001-12-27 2002-12-26 がんの予防・治療剤 Pending JP2003277288A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002376903A JP2003277288A (ja) 2001-12-27 2002-12-26 がんの予防・治療剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001-398220 2001-12-27
JP2001398220 2001-12-27
JP2002376903A JP2003277288A (ja) 2001-12-27 2002-12-26 がんの予防・治療剤

Publications (2)

Publication Number Publication Date
JP2003277288A JP2003277288A (ja) 2003-10-02
JP2003277288A5 true JP2003277288A5 (https=) 2006-02-02

Family

ID=29252844

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002376903A Pending JP2003277288A (ja) 2001-12-27 2002-12-26 がんの予防・治療剤

Country Status (1)

Country Link
JP (1) JP2003277288A (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2714903B1 (en) * 2011-06-03 2018-03-21 OncoTherapy Science, Inc. Suv39h2 as a target gene for cancer therapy

Similar Documents

Publication Publication Date Title
EP1999149A4 (en) ANTI-IGF-1R ANTIBODIES AND USES THEREOF
MX2008001509A (es) Peptidos protectores de tejido y sus usos.
WO2003016475A3 (en) Nucleic acid and amino acid sequences involved in pain
WO2004006838A3 (en) Novel kinases
WO2003089456A3 (en) Peptide inhibitors of protein kinase c
WO2006108718B1 (en) Micro rna
WO2003013534A3 (en) Methods for the treatment of cancer with irinotecan based on cyp3a5
WO2001055178A3 (en) Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer
BR0306715A (pt) Métodos para diagnóstico e tratamento de tumores
WO2002061076A1 (fr) Proteine associee a l'adiponectine
MXPA02008239A (es) Gen humano de la esquizofrenia.
ATE536745T1 (de) Zusammensetzung mit arazym zur prävention und behandlung von krebs
WO2001004157A3 (en) NOVEL METHOD AND COMPOSITION FOR INHIBITION OF ANGIOGENESIS USING ANTAGONISTS BASED ON MMP-9 AND β1 INTEGRINS
IL149416A0 (en) Human enzymes of the metalloprotease family
JP2003277288A5 (https=)
JP2003277289A5 (https=)
DE69924877D1 (en) Humanes akt-3 protein
EP1282641A4 (en) Cervical cancer suppressing protein in women, polynucleotide encoding it, cell transformed by polynucleotide, and method of suppressing proliferation of cancer cells using the expression vector
WO2005023186A3 (en) Methods of identifying agents that inhibit the growth of cancer cells
TW200517125A (en) Pharmaceutical composition for treatment of solid cancers
EP1666880A4 (en) SCREENING PROCESS
WO2002070559A3 (en) Nuclear hormone receptor ligand binding domains
WO2003037257A3 (en) Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 20750
JP2002355060A5 (https=)
JP2004073182A5 (https=)